Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21370176 | 0.94 | CYP11B1 (0.39) | CYP11B1KDM4EL3MBTL1ALDH1A1MAPT | |
| SCHEMBL21369774 | 0.94 | CYP11B1 (0.41) | CYP11B1KDM4EL3MBTL1ATMPARP1 | |
| SCHEMBL21369827 | 0.89 | KDM4E (0.35) | KDM4EL3MBTL1ATMPARP1MAPT | |
| SCHEMBL21370263 | 0.88 | CYP11B1 (0.36) | CYP11B1KDM4EL3MBTL1ATMALDH1A1 | |
| SCHEMBL21370261 | 0.88 | CYP11B1 (0.36) | CYP11B1KDM4EL3MBTL1ATMALDH1A1 | |
| SCHEMBL21370202 | 0.87 | MEN1 (0.37) | CYP11B1KDM4EL3MBTL1ATMALDH1A1 | |
| SCHEMBL21370205 | 0.87 | MEN1 (0.37) | CYP11B1KDM4EL3MBTL1ATMALDH1A1 | |
| SCHEMBL21370215 | 0.87 | CYP11B1 (0.36) | CYP11B1KDM4EL3MBTL1ATMALDH1A1 | |
| SCHEMBL21370319 | 0.86 | CYP11B1 (0.34) | CYP11B1KDM4EL3MBTL1ATMALDH1A1 | |
| SCHEMBL21369881 | 0.86 | CYP11B1 (0.36) | CYP11B1KDM4EL3MBTL1ATMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190288215-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | SOULBRAIN CO., LTD. (KR) | 2019-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190288215-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CYP1A1, CYP1B1 | CYP11B1 37/4885KDM4E 2473/4885L3MBTL1 1787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.